Wednesday, September 6, 2006
Artisan Pharma Inc., a four-person Framingham company, said today it had won $39 million in venture-capital financing to develop a Japanese company's experimental drug to reduce blood clotting and inflammation. The drug, made by Asahi Kasei Pharma Corp., is awaiting approval in Japan.
Artisan, formed by venture investors a month ago to license the drug from AKP, plans to hire several employees and begin conducting clinical trials in the United States starting next year.
-- Stephen Heuser